Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/21/1999CA2327339A1 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient
10/21/1999CA2327282A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
10/21/1999CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999CA2326618A1 Inhibition of xenoreactive antibodies
10/21/1999CA2326349A1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325718A1 Antimicrobial agent
10/21/1999CA2325630A1 Use of a porphyrin for producing a medicine reducing the number of eosinophils
10/21/1999CA2325629A1 Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide
10/21/1999CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999CA2324363A1 Coated starch capsules and a process for producing them
10/21/1999CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999CA2321157A1 New treatments for nervous disorders
10/21/1999CA2320722A1 New treatments for nervous disorders
10/21/1999CA2293605A1 Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
10/21/1999CA2293453A1 13-dihydro-3'aziridino anthracyclines
10/20/1999EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases
10/20/1999EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999EP0950417A2 Treatment of skeletal disorders
10/20/1999EP0950414A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/20/1999EP0950413A2 Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
10/20/1999EP0950412A2 Compositions for treating allergic disorders using (-) cetirizine
10/20/1999EP0950411A1 Process of manufacturing an extract from the Copalchi stem barks and the use of neoflavonoids for the treatment of diabetes
10/20/1999EP0950410A1 Conjugated linoleic acid compositions
10/20/1999EP0950409A1 Subepithelial turbidity inhibitor
10/20/1999EP0950408A1 Oily patches for external use containing diclofenac sodium
10/20/1999EP0950407A1 Method for transdermal administration of GP IIb/IIIa antagonist
10/20/1999EP0950406A2 Remedy for CAG repeat expansion diseases
10/20/1999EP0950405A1 Remedies for renal diseases and organ-preserving agents
10/20/1999EP0950060A1 Antisense inhibition of human adhesion molecules
10/20/1999EP0950059A1 Cyclic sulfone derivatives
10/20/1999EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999EP0950057A1 3-pyridyl enantiomers and their use as analgesics
10/20/1999EP0950056A2 N-(pyridinylamino)isoindolines and related compounds
10/20/1999EP0950054A1 Substituted heterocycles as anti-tumor agents
10/20/1999EP0950053A1 Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
10/20/1999EP0950052A1 Method for preparing a tetrahydropyridin derivative
10/20/1999EP0950051A1 Micro-particulate form of a tetrahydropyridin derivative
10/20/1999EP0950050A1 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
10/20/1999EP0950049A1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/20/1999EP0950048A1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
10/20/1999EP0950047A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/20/1999EP0949931A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
10/20/1999EP0949928A1 Androgenic and bisphosphonic agents coadministered to treat diseases
10/20/1999EP0949927A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
10/20/1999EP0949926A1 Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase
10/20/1999EP0949925A2 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
10/20/1999EP0949924A1 Use of cyanines, isocyanines and pseudoisocyanines as diuretics
10/20/1999EP0949923A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
10/20/1999EP0949922A1 Pharmaceutical compositions and methods of treating compulsive disorders using naaladase inhibitors
10/20/1999EP0949921A1 Thrombin inhibitors
10/20/1999EP0949920A1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
10/20/1999EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999EP0949918A1 7-deoxy-6-substituted paclitaxels
10/20/1999EP0949917A1 Substances and their uses
10/20/1999EP0949915A1 Nitrone free radical trap treatment of dementia associated with aids virus (hiv-1) infection
10/20/1999EP0949914A1 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens and tumors
10/20/1999EP0949911A1 Biodegradable ionic matrix of variable internal polarity with grafted polymer
10/20/1999EP0949904A1 Pharmaceutical compositions
10/20/1999EP0949890A1 Nicotine metabolites, nicotine dependence and human body weight
10/20/1999EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999EP0832078B1 N-hydroxyureas as antiinflammatory agents
10/20/1999EP0788476B1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
10/20/1999EP0787119B1 Salts of aminoalcohols and pharmaceutical formulations containing them
10/20/1999EP0767660B1 Methods and formulations for modulating the human sexual response
10/20/1999EP0767659B1 Transdermal administration of oxybutynin
10/20/1999EP0766689B1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof
10/20/1999EP0740655B1 Metalloproteinase inhibitors
10/20/1999EP0717738B1 Substituted oxazine and thiazine oxazolidinone antimicrobials
10/20/1999EP0708651B1 Therapeutic agent
10/20/1999EP0673250B1 Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis
10/20/1999EP0663958A4 Inhibition of cyst formation by cytoskeletal specific drugs.
10/20/1999EP0643581B1 Ocular androgen therapy in sjögren's syndrome
10/20/1999CN1232509A Catalytic nucleic acid and its medical use
10/20/1999CN1232507A Process for preparing fat oil contg. unsaturated fatty acid
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232470A GLP-1 derivs.
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232464A Substd. N-isothiazolyl-(thio) amides
10/20/1999CN1232462A Muscarinic antagonists
10/20/1999CN1232461A Neuraminic acid compounds
10/20/1999CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs.
10/20/1999CN1232453A Ether muscarinic antagonists
10/20/1999CN1232452A NMDA (N-methyl-D-aspartate) antagonists
10/20/1999CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999CN1232448A Vitamin D analogues
10/20/1999CN1232447A Hydroxamic acid derivs.
10/20/1999CN1232443A Novel p-terphenyl compounds
10/20/1999CN1232399A Inhibitors of cysteine protease
10/20/1999CN1232398A IL-8 receptor antagonists
10/20/1999CN1232397A Use of H+, K+-ATPase inhibitor in treatment of nasal polyps
10/20/1999CN1232396A Agent for inhibition of cytokine production and agent for inhibition of cell adhesion
10/20/1999CN1232395A Pharmaceutical compound comprising polyamines substd. with electron-affinic groups
1 ... 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 ... 7860